Potential of Gd-EOB-DTPA As an Imaging Biomarker for Liver Injury Estimation After Radiation Therapy
Overview
Affiliations
Background: Hepatic radiation injury severely restricts irradiation treatment for liver carcinoma. The purpose of this study was to investigate the clinical application of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gd-EOB-DTPA)-enhanced MRI (EOB-MRI) in the assessment of liver function after external radiation therapy and to determine the relationship between focal liver reaction (FLR) and liver function.
Methods: A total of 47 patients with liver malignancies who underwent external beam radiation therapy were enrolled. EOB-MRI was performed on each patient at approximately one month post-radiotherapy. The hepatobiliary (HPB) phase images from EOB-MRI were fused with the planning CT images, and the isodose lines from the patients' treatment plans were overlaid onto the fused images. The correlation of the EOB-MR image intensity distribution with the isodose lines was studied. We also compared liver function in patients between pre-treatment and post-treatment.
Results: Decreased uptake of Gd-EOB-DTPA, which was manifested by well-demarcated focal hypointensity of the liver parenchyma or FLR to high-dose radiation, was observed in the irradiated areas of 38 patients. The radiotherapy isodose line of decreased uptake area of Gd-EOB-DTPA was 30-46 Gy. The median corresponding dose curve of FLR was 34.4 Gy. Nine patients showed the absence of decreased uptake area of Gd-EOB-DTPA in the irradiated areas. Compared to the 38 patients with the presence of decreased uptake area of Gd-EOB-DTPA, 9 patients with the absence of decreased uptake area of Gd-EOB-DTPA showed significant higher levels of total bile acid, total bilirubin, direct bilirubin and alpha-fetoprotein (P < 0.05). There were no significant differences in alanine transaminase, aspartate aminotransferase, gamma-glutamyl transpeptidase or albumin levels between the two groups (P > 0.05).
Conclusions: Visible uptake of Gd-EOB-DTPA by the liver parenchyma was significantly associated with liver function parameters. EOB-MRI can be a valuable imaging biomarker for the assessment of liver parenchyma function outside of radiation area.
Fabritius M, Garlipp B, Ocal O, Puhr-Westerheide D, Amthauer H, Geyer T Eur Radiol Exp. 2024; 8(1):15.
PMID: 38282160 PMC: 10822831. DOI: 10.1186/s41747-023-00409-x.
Nehlsen A, Sindhu K, Wolken T, Khan F, Kyriakakos C, Ward S Radiol Imaging Cancer. 2022; 4(4):e210100.
PMID: 35904411 PMC: 9358658. DOI: 10.1148/rycan.210100.
Usami A, Yokoyama K, Tsuchiya J, Umezawa Y, Toda K, Tateishi U Diagnostics (Basel). 2022; 12(2).
PMID: 35204594 PMC: 8870758. DOI: 10.3390/diagnostics12020504.
Ebara M, Shibuya K, Shimada H, Kawashima M, Hirasawa H, Taketomi-Takahashi A Adv Radiat Oncol. 2021; 6(6):100775.
PMID: 34934860 PMC: 8655403. DOI: 10.1016/j.adro.2021.100775.
Ouyang Q, Liang G, Tan X, He X, Zhang L, Kuang W Sci Rep. 2021; 11(1):4117.
PMID: 33603011 PMC: 7892848. DOI: 10.1038/s41598-021-83202-3.